Category: General Cardiology
General Cardiology
Rivaroxaban is direct, specific, competitive factor Xa inhibitor and it has a half life of five to thirteen hours.
Read More
General Cardiology
In patients with atherosclerotic cardiovascular disease and LDL levels below 70 mg/dl, there was no added benefit by giving niacin along simvastatin.
Read More
General Cardiology
Vorapaxar to standard therapy did not reduce the primary composite end point, but increased risk of major bleeding including intracranial hemorrhage.
Read More
General Cardiology
Dabigatran: Class I recommendation (level of evidence B) as an alternative to warfarin for the prevention of stroke and systemic thromboembolism in AF
Read More
General Cardiology
Controversies in assessing and managing CVD risk in patients with diabetes
Read More
General Cardiology
non HDL cholesterol is the marker of better choice at present as it has established cut off points with safe and achievable goals.
Read More
General Cardiology
Platypnea-orthodeoxia is characterized by dyspnoea and systemic oxygen desaturation on assuming the sitting or standing position.
Read More
General Cardiology
Components of mitral valve apparatus: mitral annulus, mitral leaflets, chordae tendinae, papillary muscles and adjoining portions of the LV and LA.
Read More
General Cardiology
Universal definition of myocardial infarction has been under the joint auspices of the ESC, ACCF, AHA and World Heart Federation.
Read More
General Cardiology
Cardiorenal syndrome has been classified into types I, II, III, IV and V.
Read More